Entertainment Wire Massachusetts: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Entertainment Wire Massachusetts.

Press releases published on October 22, 2026

Oct. 22, 2026

Vericel to Report Third Quarter 2026 Financial Results on November 5, 2026

Indeterminate GlobeNewswire

Oct. 22, 2026

Alpha Tau and Samsung Medical Center Sign MOU to Explore Clinical Trial of Alpha DaRT® for Pancreatic Cancer Patients in Korea

Indeterminate GlobeNewswire

Oct. 22, 2026

IBN Initiates Coverage of ECGI Holdings Inc.

Indeterminate GlobeNewswire

Oct. 22, 2026

AI Visibility for Private Equity Firms: Study Finds No Firm Named in More Than 15% of 4,000 AI Answers

Indeterminate GlobeNewswire

Oct. 22, 2026

Candel Therapeutics Appoints Maria Ostrovsky as General Counsel

Indeterminate GlobeNewswire

Oct. 22, 2026

Tiangong Kaiwu, Connecting the World Dialogue on High-Quality Industrial Development Held in Xinyu, Jiangxi

Indeterminate GlobeNewswire

Oct. 22, 2026

First Steps Developmental Services Opens Infant Assessment in Woburn

Indeterminate GlobeNewswire

Oct. 22, 2026

Collegium to Report Third Quarter 2026 Financial Results on November 5, 2026

Indeterminate GlobeNewswire

Oct. 22, 2026

Corbus Pharmaceuticals to Present Late Breaking CRB-913 Data from Canyon-1 Study at Obesity Week® 2026

Indeterminate GlobeNewswire

Oct. 22, 2026

Cambridge Heavy Industries Raises $6.2 Million Seed Round to Advance its Modular, Benchtop-scale Fusion System Technology

Indeterminate GlobeNewswire

Oct. 22, 2026

Rectify to Present Translational Data Supporting RTY-406 as a Transformative Therapy for PSC and Other Hepatobiliary Diseases

Indeterminate GlobeNewswire

Oct. 22, 2026

Replimune to Report the Fiscal Second Quarter 2027 Financial Results and Provide Corporate Update on October 28, 2026

Indeterminate GlobeNewswire

Oct. 22, 2026

Aspen Aerogels, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call

Indeterminate GlobeNewswire

Oct. 22, 2026

Rgenta Therapeutics Announces Successful End-of-Phase 2 Meeting with FDA and Alignment on Phase 3 Trial Design for RGT-61159 in Patients with Adenoid Cystic Carcinoma (ACC)

Indeterminate GlobeNewswire

Oct. 22, 2026

The End of the Flat White? Oatly’s Future of Taste Report Identifies Four Key Trends Shaping Café Menus

Indeterminate GlobeNewswire

Oct. 22, 2026

Acumen Pharmaceuticals to Present Preliminary Baseline Characteristics and Data on Care Experiences and Participation in Phase 2 ALTITUDE-AD Trial at the 19th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Indeterminate GlobeNewswire

Oct. 22, 2026

BPGbio Appoints Jason Krause as Senior Vice President and General Counsel

Indeterminate GlobeNewswire

Oct. 22, 2026

Generate Biomedicines to Participate in November Investor Conferences

Indeterminate GlobeNewswire

Oct. 22, 2026

Korro Reports Best-in-Class Preclinical Data for KRRO-111 Demonstrating Potential to Benefit Lung and Liver Manifestations of Alpha-1 Antitrypsin Deficiency

Indeterminate GlobeNewswire

Oct. 22, 2026

Global Times: Financial Street Forum highlights openness, win-win cooperation to advance high-quality BRI development

Indeterminate GlobeNewswire